Delivery Order SPE2DB20D3103-SPE2DB25FM5B7

Award Date 1/29/25
Potential Completion Date 1/30/25
Potential Value $51K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of LUPRON DEPOT-PED 15 MG KITS. The fixed-price contract, valued at $11,029.35, has a completion date of December 5, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $54,256.97 delivery order contract is for the supply of LUPRON DEPOT-PED 11.25 MG 3MOS, a specialty medication, with a completion date of August 12, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $93,846.87, is for the delivery of LUPRON DEPOT-PED 11.25 MG 3MOS, a pediatric medication used for the treatment of central precocious puberty. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $90,904.96 firm fixed-price delivery order is for the supply of LUPRON DEPOT-PED 30 MG 3MO KITS, a specialty medication. The contract has an ultimate completion date of June 10, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor) is for the delivery of Lupron Depot-Ped 11.25 mg (a specialty medication) to support the Defense Logistics Agency's (DLA) medical supply needs. The firm-fixed-price contract, valued at $18,648.91, has a period of performance through November 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,627.91 firm fixed-price delivery order is for LUPRON DEPOT 11.25 MG 3MO KITS, with a completion date of November 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a...
This federal contract award is for the delivery of LUPRON DEPOT-PED 11.25 MG 3MOS medication to the Defense Logistics Agency (DLA). The $86,491.75 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $80,903.54, is for the delivery of Lupron Depot-Ped 11.25 mg 3 months, a specialty medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 28, 2022. No set-aside requirements were designated for this award. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,974.32 firm fixed-price delivery order contract is for the supply of LUPRON DEPOT 3.75 MG KITS, a specialty medication used in various medical treatments. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,080.81 firm fixed-price delivery order contract is for the supply of LUPRON DEPOT-PED 30 MG 3MO KITS, a specialty pharmaceutical product. The award has an ultimate completion date of February 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM5B7
    Delivery Order

This federal contract award, valued at $50,605.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4567090418 ! LUPRON DEPOT-PED 11.25 MG 3MOS, a pharmaceutical product. The contract has a firm fixed-price structure and a period of performance through January 30, 2025.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

This specific contract award was not designated with any set-aside requirements, indicating open competition. The award is associated with a larger IDC contract, which enables efficient government procurement of essential pharmaceutical and medical supplies to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/30/25, 9:55 AM